期刊文献+

脓毒症脑病发病机制的研究进展 被引量:5

Research Progress in Pathogenesis of Septic Encephalopathy
下载PDF
导出
摘要 脓毒症脑病(SAE)是脓毒症常见的并发症,与重症监护病房较高的病死率相关,同时也与SAE患者不良的预后以及长期的认知功能障碍相关。SAE的主要发病机制可能涉及神经递质功能障碍、脑部炎症性、缺血性病变以及血脑屏障功能障碍等。由于SAE的诊断标准及排除标准目前尚未达成共识,且无客观的诊断指标,患者总住院时间延长、伤残率和病死率升高。因此,针对SAE发病机制的研究具有重要临床意义,但目前SAE的病理生理机制尚未完全阐明,还有待未来进一步研究。 Sepsis-associated encephalopathy(SAE)is a kind of common complications of sepsis,which is related to a higher mortality in intensive care unit,and poor prognosis and long-term cognitive dysfunction of the SAE patients.The major pathogenesis of SAE may involve neurotransmitter dysfunction,brain inflammation,ischemic lesions,and blood-brain barrier dysfunction.There is no consensus on the diagnostic criteria and exclusion criteria of SAE,and the objective diagnostic indicators are still in lack,leading to prolonged hospitalization,and increased disability and mortality rate.Therefore,the research on the pathogenesis of SAE has great clinical significance,whereas currently pathophysiological mechanism of SAE has not yet been fully elucidated,and further research is needed in the future.
作者 李志强 周艺蕉 杨春燕 LI Zhiqiang;ZHOU Yijiao;YANG Chunyan(Department of Emergency Critical Care Medicine,the Second Affiliated Hospital of Kunming Medical University,Kunming 650101,China)
出处 《医学综述》 CAS 2021年第19期3791-3795,共5页 Medical Recapitulate
基金 云南省教育厅科学研究基金(2021J0255) 昆明医科大学第二附属医院院内科技计划项目(2020yk009)。
关键词 脓毒症脑病 脓毒症 血脑屏障 Sepsis-associated encephalopathy Sepsis Blood-brain barrier
  • 相关文献

参考文献5

二级参考文献55

  • 1张荣丽,何伟,李彤,周华,王超,高爽,许媛.重症患者血糖控制目标的探讨[J].中国临床营养杂志,2008,16(4):204-208. 被引量:10
  • 2孙海梅,况铣,魏宏建.小剂量多巴胺在脓毒症中的应用研究进展[J].中国综合临床,2006,22(2):188-190. 被引量:4
  • 3韩国强,潘国权.去甲肾上腺素并多巴酚丁胺治疗脓毒性休克伴顽固性低血压28例临床分析[J].中国急救医学,2006,26(6):426-428. 被引量:10
  • 4Marshall JC, Vincent JL, Guyatt G, et al. Outcome measures for clini- cal research in sepsis : a report of the 2nd Cambridge Colloquium of the International Sepsis Forum [ J ]. Crit Care Med, 2005,33 ( 8 ) : 1708-1716.
  • 5Hill AL, Lowes DA, Webster NR, et al. Regulation of pentraxin-3 by antioxidants [ J]. Br J Anaesth ,2009,103 (6) :833-839.
  • 6Brealey DA,Hargreaves I,Heales S,et al. Recovery fi'om organ fail- ure is associated with improved mitochondrial function in septic patients (abstract) [ J]. Intensive Care Med,2003,29(2) :S134.
  • 7Gong P, Li CS. Sepsis and mitochondrial dysfunction [ J ]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,2013,25(4) :254-256.
  • 8Rocha M, Herance R, Rovira S, et al. Mitochondrial dysfunction and antioxidant therapy in sepsis [ J ]. Infect Disord Drug Targets, 2012, 12(2) :161-178.
  • 9Subramanian S, Kalyanaraman B, Migrino RQ. Mitochondrially targe- ted antioxidants for the treatment of cardiovascular diseases [ J ]. Re- cent Pat Cardiovasc Drug Discov,2010,5 ( 1 ) :54-65.
  • 10Plotnikov EY, Morosanova MA, Pevzner 113, et al. Protective effect of mitochondria-targeted antioxidants in an acute bacterial infection[ J]. Proc Nail Acad Sci U S A,2013,110(33) :E3100-3108.

共引文献796

同被引文献44

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部